FDA Approved: REGLAN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for REGLAN (metoclopramide hydrochloride), enabling changes under a supplemental NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Diabetic Gastroparesis
• Gastroesophageal Reflux Disease
• Gastroparesis
• Postoperative Nausea and Vomiting

Drugs mentioned

• Reglan (metoclopramide)

Snippet

SUPPL AP for REGLAN (METOCLOPRAMIDE HYDROCHLORIDE)